Sinco Pharmaceutical Holdings Ltd

06833

Company Profile

  • Business description

    Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.

  • Contact

    No. 1700, North Section of Tianfu Avenue
    E5-1805, Global Centre
    High-Tech Zone, Chengdu
    Sichuan Province
    Chengdu
    CHN

    T: +86 2862912988

    https://www.sinco-pharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    31 December 2026

    Employees

    268

Stocks News & Analysis

stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.
stocks

Our Tesla fair value increases meaningfully

Progress on Robotaxi and Optimus shows real world AI growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,164.8094.40-1.02%
CAC 408,129.3057.940.72%
DAX 4024,515.31205.850.85%
Dow JONES (US)49,071.5655.960.11%
FTSE 10010,209.7537.990.37%
HKSE27,387.11580.98-2.08%
NASDAQ23,685.12172.33-0.72%
Nikkei 22553,322.8552.75-0.10%
NZX 50 Index13,423.1874.570.56%
S&P 5006,969.010.000.00%
S&P/ASX 2008,869.1086.00-0.96%
SSE Composite Index4,117.9540.04-0.96%

Market Movers